Thompson Siegel & Walmsley’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-37,442
Closed -$2.07M 413
2025
Q2
$2.07M Sell
37,442
-50,027
-57% -$2.35M 0.03% 260
2025
Q1
$3.82M Sell
87,469
-33,318
-28% -$1.45M 0.06% 213
2024
Q4
$5.2M Buy
120,787
+99,220
+460% +$4.47M 0.08% 198
2024
Q3
$963K Sell
21,567
-2,631
-11% -$109K 0.01% 292
2024
Q2
$931K Sell
24,198
-147,474
-86% -$5.62M 0.01% 280
2024
Q1
$5.91M Sell
171,672
-5,333
-3% -$171K 0.09% 184
2023
Q4
$5.12M Buy
177,005
+54,598
+45% +$1.24M 0.08% 192
2023
Q3
$2.32M Buy
+122,407
New +$2.32M 0.04% 232

Other funds holding DBD

Thompson Siegel & Walmsley's DBD Position: Q3 2025 in Review

Thompson Siegel & Walmsley sold out of Diebold Nixdorf (DBD) in Q3 2025, closing a stake of 37,442 shares — an estimated $2.07M sold.

Thompson Siegel & Walmsley first reported a position in DBD in Q3 2023 and held it in 8 quarters. The position peaked at $5.91M in Q1 2024. 164 funds tracked by Wall St. Rank hold DBD as of Q3 2025.

  • Thompson Siegel & Walmsley reported no remaining Diebold Nixdorf position as of Q3 2025 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 37,442 Diebold Nixdorf shares in Q3 2025, an estimated $2.07M.
  • Thompson Siegel & Walmsley first reported a position in Diebold Nixdorf in Q3 2023 and held it in 8 quarters.
  • Thompson Siegel & Walmsley's Diebold Nixdorf position peaked at $5.91M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q3 2025.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2025, filed 12 Nov 2025.